Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6

Shinichiro Takahashi1, Hideo Harigae, Keiko Kumura Ishii

  • 1Department of Clinical Laboratory Medicine, Tohoku University School of Medicine, 1-1 Seiryou-machi, Aobaku, Sendai 980-8574, Japan. shintak@mail.tains.tohoku.ac.jp

Leukemia Research
|June 28, 2005
PubMed

Insights

Activating Fms-like tyrosine kinase 3 (Flt3) mutations in acute myeloblastic leukemia (AML) activate signaling pathways. This study reveals Flt3 signaling upregulates nuclear factor-kappa B (NF-kappaB) and its target IL-6, suggesting Flt3

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Activating mutations or over-expression of Fms-like tyrosine kinase 3 (Flt3) are common in acute myeloblastic leukemia (AML).
  • Flt3 signaling activates Ras/MAP kinase and other pathways crucial in cancer development.
  • Nuclear factor-kappa B (NF-kappaB) is a key transcription factor regulated by these kinase pathways.

Purpose of the Study:

  • To investigate the role of Flt3 in the activation of the NF-kappaB signaling pathway.
  • To determine if Flt3 signaling influences the expression of NF-kappaB target genes, such as Interleukin-6 (IL-6).

Main Methods:

  • Utilized BaF3 cells engineered for stable Flt3 expression.
  • Employed an NF-kappaB-responsive reporter assay to measure pathway activation.
  • Quantified IL-6 mRNA expression in cell lines and primary AML specimens.
  • Analyzed the correlation between Flt3 and IL-6 mRNA levels in AML patient samples.

Main Results:

  • Flt3 expression led to the upregulation of an NF-kappaB-responsive reporter in BaF3 cells.
  • Flt3 signaling, specifically through the Flt3-ERK/MAPK pathway, resulted in increased IL-6 expression.
  • A modest positive correlation (r=0.35, p=0.096) was observed between Flt3 and IL-6 mRNA levels in 24 AML specimens.

Conclusions:

  • Flt3 signaling plays a role in the activation of the NF-kappaB pathway.
  • Flt3 over-expression may contribute to the pathogenesis of AML by upregulating NF-kappaB and IL-6.
  • These findings highlight a potential therapeutic target in Flt3-driven AML.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...